— Know what they know.
Not Investment Advice

PBE

Invesco Biotechnology & Genome ETF
1W: -0.2% 1M: +1.4% 3M: +0.4% YTD: -0.2% 1Y: +30.5% 3Y: +33.9% 5Y: +16.4%
$82.15
+0.10 (+0.12%)
 
Weekly Expected Move ±2.4%
$77 $79 $81 $83 $85
ETF AMEX · AUM $252.5M
Key Statistics
AUM$253M
Holdings31
Top 10 Wt46.5%
Volume2,586
Avg Volume6,909
Beta0.81
Portfolio Fundamentals
P/E21.5
P/B5.5
Div Yield0.34%
ROE26.4%
% Profitable70%
Inception2005-06-23
Sector Allocation
Healthcare 100.0%
Financial Services 0.0%
Other 0.0%
Top 10 Holdings
# Name Ticker Weight % Market Value Shares
1 United Therapeutics Corp UTHR 6.03% $15.2M 27,038
2 Illumina Inc ILMN 5.84% $14.8M 104,158
3 Biogen Inc BIIB 4.87% $12.3M 65,601
4 Incyte Corp INCY 4.86% $12.3M 126,679
5 Alnylam Pharmaceuticals Inc ALNY 4.54% $11.5M 38,458
6 Gilead Sciences Inc GILD 4.48% $11.3M 86,702
7 Amgen Inc AMGN 4.42% $11.1M 33,435
8 Regeneron Pharmaceuticals Inc REGN 4.26% $10.8M 16,576
9 TG Therapeutics Inc TGTX 3.60% $9.1M 228,853
10 Catalyst Pharmaceuticals Inc CPRX 3.57% $9.0M 288,645

Recent Holding Changes

Date Holding Change Details
2026-05-22 AGPXX Changed 49691 → 28680
2026-05-18 AGPXX Changed 147782 → 49691
2026-05-07 VCEL Changed 183726 → 182544
2026-05-07 RPRX Changed 154791 → 153795
2026-05-07 CPRX Changed 290513 → 288645

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms